216 related articles for article (PubMed ID: 34906330)
1. Estrogen receptor alpha and NFATc1 bind to a bone mineral density-associated SNP to repress WNT5B in osteoblasts.
Suthon S; Lin J; Perkins RS; Crockarell JR; Miranda-Carboni GA; Krum SA
Am J Hum Genet; 2022 Jan; 109(1):97-115. PubMed ID: 34906330
[TBL] [Abstract][Full Text] [Related]
2. GATA4 and estrogen receptor alpha bind at SNPs rs9921222 and rs10794639 to regulate AXIN1 expression in osteoblasts.
Suthon S; Perkins RS; Lin J; Crockarell JR; Miranda-Carboni GA; Krum SA
Hum Genet; 2022 Dec; 141(12):1849-1861. PubMed ID: 35678873
[TBL] [Abstract][Full Text] [Related]
3. GATA4 regulates estrogen receptor-alpha-mediated osteoblast transcription.
Miranda-Carboni GA; Guemes M; Bailey S; Anaya E; Corselli M; Peault B; Krum SA
Mol Endocrinol; 2011 Jul; 25(7):1126-36. PubMed ID: 21566084
[TBL] [Abstract][Full Text] [Related]
4. Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate.
Fromigué O; Haÿ E; Barbara A; Marie PJ
J Biol Chem; 2010 Aug; 285(33):25251-8. PubMed ID: 20554534
[TBL] [Abstract][Full Text] [Related]
5. A DNA binding mutation in estrogen receptor-α leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts.
Mödder UI; Rudnik V; Liu G; Khosla S; Monroe DG
J Cell Biochem; 2012 Jul; 113(7):2248-55. PubMed ID: 22573547
[TBL] [Abstract][Full Text] [Related]
6. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts.
Penolazzi L; Zennaro M; Lambertini E; Tavanti E; Torreggiani E; Gambari R; Piva R
Mol Pharmacol; 2007 Jun; 71(6):1457-62. PubMed ID: 17389747
[TBL] [Abstract][Full Text] [Related]
7. GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways.
Güemes M; Garcia AJ; Rigueur D; Runke S; Wang W; Zhao G; Mayorga VH; Atti E; Tetradis S; Péault B; Lyons K; Miranda-Carboni GA; Krum SA
J Bone Miner Res; 2014 Dec; 29(12):2676-87. PubMed ID: 24932701
[TBL] [Abstract][Full Text] [Related]
8. Genistein induces oestrogen receptor-α gene expression in osteoblasts through the activation of mitogen-activated protein kinases/NF-κB/activator protein-1 and promotes cell mineralisation.
Liao MH; Tai YT; Cherng YG; Liu SH; Chang YA; Lin PI; Chen RM
Br J Nutr; 2014 Jan; 111(1):55-63. PubMed ID: 23829885
[TBL] [Abstract][Full Text] [Related]
9. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.
Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW
J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the estrogen receptor alpha signaling delays bone regeneration and alters osteoblast maturation, energy metabolism, and angiogenesis.
Wu GJ; Chen JT; Lin PI; Cherng YG; Yang ST; Chen RM
Life Sci; 2020 Oct; 258():118195. PubMed ID: 32781073
[TBL] [Abstract][Full Text] [Related]
11. A specific haplotype in potential miRNAs binding sites of secreted frizzled-related protein 1 (SFRP1) is associated with BMD variation in osteoporosis.
Amjadi-Moheb F; Hosseini SR; Kosari-Monfared M; Ghadami E; Nooreddini H; Akhavan-Niaki H
Gene; 2018 Nov; 677():132-141. PubMed ID: 30055306
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone.
Syed FA; Fraser DG; Monroe DG; Khosla S
Bone; 2011 Aug; 49(2):208-16. PubMed ID: 21458604
[TBL] [Abstract][Full Text] [Related]
13. ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways.
Yin X; Wang X; Hu X; Chen Y; Zeng K; Zhang H
Exp Cell Res; 2015 Jul; 335(1):107-14. PubMed ID: 25957463
[TBL] [Abstract][Full Text] [Related]
14. High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1.
Wang R; Gao D; Zhou Y; Chen L; Luo B; Yu Y; Li H; Hu J; Huang Q; He M; Peng W; Luo D
J Steroid Biochem Mol Biol; 2017 Nov; 174():276-283. PubMed ID: 29030155
[TBL] [Abstract][Full Text] [Related]
15. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
[TBL] [Abstract][Full Text] [Related]
16. Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts.
Chang W; Parra M; Centrella M; McCarthy TL
Gene; 2005 Jan; 345(2):225-35. PubMed ID: 15716114
[TBL] [Abstract][Full Text] [Related]
17. Genistein Improves Bone Healing via Triggering Estrogen Receptor Alpha-Mediated Expressions of Osteogenesis-Associated Genes and Consequent Maturation of Osteoblasts.
Wu GJ; Chen JT; Cherng YG; Chang CC; Liu SH; Chen RM
J Agric Food Chem; 2020 Sep; 68(39):10639-10650. PubMed ID: 32897066
[TBL] [Abstract][Full Text] [Related]
18. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.
Zhou S; Zilberman Y; Wassermann K; Bain SD; Sadovsky Y; Gazit D
J Cell Biochem Suppl; 2001; Suppl 36():144-55. PubMed ID: 11455579
[TBL] [Abstract][Full Text] [Related]
19. Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalpha.
Almeida M; Martin-Millan M; Ambrogini E; Bradsher R; Han L; Chen XD; Roberson PK; Weinstein RS; O'Brien CA; Jilka RL; Manolagas SC
J Bone Miner Res; 2010 Apr; 25(4):769-81. PubMed ID: 19821774
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of beta-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency.
Foo C; Frey S; Yang HH; Zellweger R; Filgueira L
Gynecol Endocrinol; 2007 Sep; 23(9):535-40. PubMed ID: 17852416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
